hotspot -WSS

hotspot

author：explore 2025-10-01 10:58:00 - browse：3

Cambridge: AbbVie — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. Ruby Wallau for STAT

WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

WSS

How corporate America is slashing DEI workers amid backlash to diversity programs

Sen. Bill Cassidy on how to lower drug prices

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

What's changing in Medicare's open enrollment this year?

Rare Northern Lights show in US this week: Where and how to see it

Takeaways from AdvaMed, the largest medical devices conference

hotspot

hotspot

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Life sciences deals on track to hit lowest point since 2017

The cancer drug shortage isn’t new — and neither are the solutions

Humana CEO Bruce Broussard to step down in 2024

Medical leaders decry Supreme Court decision on affirmative action

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

Hepatitis C has a cure — but many Americans still lack access to it

Medicare to cover more brain scans related to Alzheimer’s drugs

Affirmative action in medical school literally saved lives

Humana CEO Bruce Broussard to step down in 2024

hotspot

What's changing in Medicare's open enrollment this year?

A fraught question for the kids of Alzheimer’s: Is it coming for us?

European regulators consider appeal over Amylyx ALS drug

Another man arrested in connection with shooting at Kansas nightclub

What's changing in Medicare's open enrollment this year?

What's changing in Medicare's open enrollment this year?

explore

focus

leisure time

knowledge